Skip to main content
. 2017 Apr 27;21(8):1468–1481. doi: 10.1111/jcmm.13073

Figure 4.

Figure 4

The impact of ID4 methylation on overall survival (OS) and leukaemia‐free survival (LFS) in patients with AML. (A) OS for non‐APL; (B) LFS for non‐APL; (C) OS for AML with normal cytogenetics (CN‐AML); (D) LFS for CN‐AML.